日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial

作者更正:一线改良FOLFOX方案联合/不联合纳武利尤单抗和伊匹木单抗或FLOT方案联合纳武利尤单抗治疗晚期胃食管腺癌:一项II期多队列IKF-AIO-MOONLIGHT试验

Lorenzen, Sylvie; Goetze, Thorsten Oliver; Thuss-Patience, Peter C; Riera-Knorrenschild, Jorge; Goekkurt, Eray; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Hofheinz, Ralf Dieter; Luley, Kim Barbara; Pink, Daniel; Lindig, Udo; Folprecht, Gunnar; Schuch, Gunter; Bitzer, Michael; Heinemann, Volker; Angermeier, Stefan; Bolling, Claus; Loose, Maria; Junge, Sabine; Pauligk, Claudia; Al-Batran, Salah-Eddin

First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial

一线改良FOLFOX方案联合/不联合纳武利尤单抗和伊匹木单抗或FLOT方案联合纳武利尤单抗治疗晚期胃食管腺癌:一项II期多队列试验

Lorenzen, Sylvie; Goetze, Thorsten Oliver; Thuss-Patience, Peter C; Riera-Knorrenschild, Jorge; Goekkurt, Eray; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Hofheinz, Ralf Dieter; Luley, Kim Barbara; Pink, Daniel; Lindig, Udo; Folprecht, Gunnar; Schuch, Gunter; Bitzer, Michael; Heinemann, Volker; Angermeier, Stefan; Bolling, Claus; Loose, Maria; Junge, Sabine; Pauligk, Claudia; Al-Batran, Salah-Eddin

Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer

一项针对晚期胰腺癌或结直肠癌患者的BMS-813160(一种CCR2/5双重拮抗剂)联合化疗或纳武利尤单抗的1b/2期研究

Le, Dung T; Folprecht, Gunnar; Varghese, Anna M; Gutierrez, Martin; Noel, Marcus; Trikalinos, Nikolaos A; Chen, Eric; Dayyani, Farshid; Davis, S Lindsey; Ma, Wen Wee; BasuMallick, Atrayee; Garrido-Laguna, Ignacio; Osawa, Mayu; O'Brien, Shaun; Novosiadly, Ruslan D; Xu, Ke; Greenawalt, Danielle M; Dutta, Santanu; Twyman Saint Victor, Christina; Lenz, Heinz-Josef

Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma

Erdafitinib治疗FGFR改变的晚期或转移性胆管癌患者

Pant, Shubham; Park, Joon Oh; Su, Wu-Chou; Loriot, Yohann; Carranza, Omar; Corassa, Marcelo; Doi, Toshihiko; Qin, Shukui; Tabernero, Josep; Prenen, Hans; Folprecht, Gunnar; Winter, Helen; Dal Molin, Graziela Z; Shen, Lin; Qian, Jiaqi; Liao, Huimin; Thomas, Shibu; Sweiti, Hussein; Triantos, Spyros; Feng, Yin-Hsun

Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)

Durvalumab 和 tremelimumab 联合局部部分肿瘤消融术(射频消融术或立体定向放射治疗)治疗无法切除的转移性结直肠癌肝转移患者:EORTC-1560-GITCG 多中心单臂 II 期研究 (ILOC) 的结果

Seligmann, J; Koessler, T; Mauer, M; Evrard, S; Freedman, J; Gootjes, E C; Guckenberger, M; Govaerts, A S; Giraut, A; Ricke, J; Folprecht, G; Arnold, D; Giasafaki, P; Ducreux, M; Antunes, S; Ruers, T

European screening platform for EORTC clinical trials in advanced colorectal cancer 'SPECTAcolor'

欧洲晚期结直肠癌EORTC临床试验筛查平台“SPECTAcolor”

Folprecht, G; Morfouace, M; Collienne, M; Salazar, R; Stein, A; Elez, E; Wagner, A D; Arnold, D; Kohne, C H; Ducreux, M; Lordick, F; Borelli, B; Stevovic, A; Gorlia, T; Fontana, E; Aust, D; Golfinopoulos, V; Moehler, M; Tejpar, S

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

德国一项针对外分泌性胰腺癌患者的研究发现,17.6% 的患者被诊断患有遗传性肿瘤综合征——这是否意味着需要进行普遍的基因检测?

William, D; Bermúdez, M; Kübler, A; Kahlert, C; Distler, M; Weitz, J; Uhrig, S; Fröhlich, M; Hutter, B; Aust, D; Baretton, G; Wimberger, P; Kast, K; Meisel, C; Gieldon, L; Porrmann, J; Wagner, J; Arlt, M; Franke, M; Fischer, J; Hackmann, K; Kreutzfeldt, S; Mock, A; Heilig, C E; Lipka, D B; Teleanu, M-V; Schlenk, R F; Brors, B; Hübschmann, D; Paramasivam, N; Richter, D; Beck, K; Pfütze, K; Buchhalter, I; Weichert, W; Herold, T; Spiekermann, K; Jost, P J; Keilholz, U; Klauschen, F; Bauer, S; Siveke, J T; Kindler, T; Boerries, M; Illert, A L; Bitzer, M; Schulze-Osthoff, K; Schirmacher, P; Stenzinger, A; Horak, P; Heining, C; Folprecht, G; Fröhling, S; Glimm, H; Schröck, E; Jahn, A

Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold

利用基于患者来源类器官阈值的食管胃癌治疗分层

Schmäche, Tim; Fohgrub, Juliane; Klimova, Anna; Laaber, Karin; Drukewitz, Stephan; Merboth, Felix; Hennig, Alexander; Seidlitz, Therese; Herbst, Friederike; Baenke, Franziska; Ada, Anne-Marlen; Groß, Thomas; Wenzel, Carina; Ball, Claudia R; Praetorius, Christian; Schmidt, Thomas; Ringelband-Schilling, Barbara; Koschny, Ronald; Stenzinger, Albrecht; Roeder, Ingo; Jaeger, Dirk; Zeissig, Sebastian; Welsch, Thilo; Aust, Daniela; Glimm, Hanno; Folprecht, Gunnar; Weitz, Jürgen; Haag, Georg M; Stange, Daniel E

Concomitant metastatic head-and-neck cancer and pancreatic cancer assessed by αvβ6-integrin PET/CT using (68)Ga-Trivehexin: incidental detection of a brain metastasis

使用 (68)Ga-Trivehexin 通过 αvβ6-整合素 PET/CT 评估伴随转移性头颈癌和胰腺癌:意外发现脑转移

Rehm, Jana; Winzer, Robert; Notni, Johannes; Hempel, Sebastian; Distler, Marius; Folprecht, Gunnar; Kotzerke, Jörg

Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114)

胃和食管胃交界处腺癌R0切除术后患者接受S-1辅助治疗:一项多中心I/II期可行性研究(GMBH-STO-0114)

Heinrich, Kathrin; Heinemann, Volker; Stintzing, Sebastian; Müller, Lothar; Ettrich, Thomas J; Büchner-Steudel, Petra; Geißler, Michael; Trojan, Jörg; Moosmann, Nicolas; Folprecht, Gunnar; Schmidt, Johannes; Kanzler, Stephan; Kullmann, Frank; Moulin, Jean-Charles; Werner, Jens; Angele, Martin K; Probst, Victoria; Held, Swantje; Schulz, Christoph; Boukovala, Myrto